Art. 5 Regulation (EU) 2016/128

Specific requirements on food information

In forcesince 25 Sep 2015cited 6×
1.

Unless otherwise provided in this Regulation, food for special medical purposes shall comply with Regulation (EU) No 1169/2011.

2.

In addition to the mandatory particulars listed in Article 9(1) of Regulation (EU) No 1169/2011, the following shall be additional mandatory particulars for food for special medical purposes:

(a)

a statement that the product must be used under medical supervision;

(b)

a statement whether the product is suitable for use as the sole source of nourishment;

(c)

a statement that the product is intended for a specific age group, as appropriate;

(d)

where appropriate, a statement that the product poses a health hazard when consumed by persons who do not have the disease, disorder or medical condition for which the product is intended;

(e)

the statement ‘For the dietary management of …’ where the blank shall be filled in with the disease, disorder or medical condition for which the product is intended;

(f)

where appropriate, a statement concerning adequate precautions and contra-indications;

(g)

a description of the properties and/or characteristics that make the product useful in relation to the disease, disorder or medical condition for the dietary management of which the product is intended, in particular, as the case may be, relating to the special processing and formulation, the nutrients which have been increased, reduced, eliminated or otherwise modified and the rationale of the use of the product;

(h)

where appropriate, a warning that the product is not for parenteral use;

(i)

instructions for appropriate preparation, use and storage of the product after the opening of the container, as appropriate.

The particulars referred to in points (a) to (d) shall be preceded by the words ‘important notice’ or their equivalent.

3.

Article 13(2) and (3) of Regulation (EU) No 1169/2011 shall also apply to the additional mandatory particulars referred to in paragraph 2 of this Article.

  • Judgment of the Court (Second Chamber) of 2 March 2023. Kwizda Pharma GmbH v Landeshauptmann von Wien.Decision

    Article 5(1) and Article (2)(a), (d), (e) and (g) of that delegated regulation state: ‘(1) Unless otherwise provided in this Regulation, food for special medical purposes shall comply with Regulation … No 1169/2011. (2) In addition to …

    2 Mar 2023 · 62021CJ0760

  • Judgment of the Court (Second Chamber) of 27 October 2022. Orthomol pharmazeutische Vertriebs GmbH v Verband Sozialer Wettbewerb eV.Decision

    Furthermore, it follows from Article 5(2)(e) and (g) of that delegated regulation that each food intended for special medical purposes is to include, first, the indication of the nutritional requirements and the disease, disorder or …

    27 Oct 2022 · 62021CJ0418

  • Opinion of Advocate General Norkus delivered on 8 May 2025. Nestlé Sverige AB v Miljönämnden i Helsingborgs kommun.Decision

    Article 5 of that delegated regulation, entitled ‘Specific requirements on food information’, provides, in paragraph 1 and paragraph 2(g) thereof: ‘1. Unless otherwise provided in this regulation, food for special medical purposes …

    8 May 2025 · 62024CC0315

  • BVerwG, Urteil vom 17. September 2021 - 3 C 20/20Decision

    … § 21 Abs. 2 Satz 1 Nr. 1 der Diätverordnung einerseits sowie Art. 11 Abs. 1 der Verordnung <EU> Nr. 609/2013 i.V.m. Art. 5 Abs. 2 Buchst. e der Delegierten Verordnung <EU> 2016/128 andererseits).

    17 Sep 2021 · WBRE202100946

  • Judgment of the Court (Eighth Chamber) of 9 October 2025. Nestlé Sverige AB v Miljönämnden i Helsingborgs kommun.Decisioninterprets

    The request for a preliminary ruling concerns the interpretation of Articles 5(2)(g) and 6(2) of Commission Delegated Regulation (EU) 2016/128 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of …

    9 Oct 2025 · 62024CJ0315

  • BVerwG, Urteil vom 17. September 2021 - 3 C 21/20Decision

    … § 21 Abs. 2 Satz 1 Nr. 1 der Diätverordnung einerseits sowie Art. 11 Abs. 1 der Verordnung <EU> Nr. 609/2013 i.V.m. Art. 5 Abs. 2 Buchst. e der Delegierten Verordnung <EU> 2016/128 andererseits).

    17 Sep 2021 · WBRE202100945